News | July 23, 2008

New Contrast Delivery System Aims to Improve Efficiency

July 24, 2008 – Covidien recently launched the Optistar Elite contrast delivery system, designed to inject contrast media-related drugs into a patient’s vascular system to aid in obtaining diagnostic images when used with magnetic resonance (MR) imaging equipment.

The product recently received FDA approval and already carries a CE Mark.

The Optistar Elite aims to provide improved performance and ease of use, compared with the previous Optistar LE model.

Among the features on the Optistar Elite injector is patency check, which aids in preventing extravasation, assists in reducing the potential of certain medical errors and helps enhance clinical and work flow efficiency. Aimed at improving patient comfort, care and safety, the patency
check feature enables healthcare providers to confirm an unobstructed, or patent, fluid pathway to the patient prior to injection of contrast media-related drugs. A visual alert on the injector powerhead and on the control console also warns clinicians when the programmed pressure limit engages due to a blockage during the patency check.

The Optistar Elite, combined with the use of Covidien’s Ultraject prefilled syringes for contrast media-related drugs, can help decrease the risk of certain medication errors that may be caused by manually filling syringes. Designing the Optistar Elite to be compatible with the Ultraject prefilled syringes also eliminates syringe preparation and labeling steps, which helps meet certain regulatory requirements of the Joint Commission.

In addition, the powerhead buttons on the Optistar Elite injector are color-coordinated with the Ultraject prefilled syringes to help avoid medication errors resulting from the use of the wrong syringes and to help ensure proper procedural set up, while a status line banner guides technologists through each step of the set up process.

For more information:

Related Content

OptiStar Elite injector
Feature | Contrast Media Injectors | March 07, 2018 | Grand View Research Inc.
The global contrast media injectors market is expected to reach $1.4 billion by 2025, growing at a compound annual...
TriHealth in Cincinnati

TriHealth in Cincinnati.

Sponsored Content | Case Study | Contrast Media Injectors | March 06, 2018
The continuing search for advantages to improve workflow has radiology departments constantly searching for new...
Guerbet Presents Contrast&Care Injection Management Solution at ECR 2018
News | Contrast Media | February 28, 2018
February 28, 2018 — Guerbet will present its new Contrast&Care application, as well as other...
Guerbet to Participate in French Interventional Radiology Conference
News | Contrast Media | October 10, 2017
Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will...
ACR Offers Revised Contrast Media in Imaging Manual
News | Contrast Media | July 17, 2017
The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of...
Experience at 3 Sites Utilizing Syringe-Less Contrast Injectors
Sponsored Content | Case Study | Contrast Media Injectors | April 13, 2017
The volume of computed tomography (CT) imaging exams continues to grow in the United States,[2] adding pressure to...
contrast media
Feature | Contrast Media Injectors | March 02, 2017 | By Jeff Zagoudis
With medical imaging use on the rise, contrast media use is expected to grow as well, according to a May 2016 report...
contrast media
News | Contrast Media | December 09, 2016
At the 2016 Annual Meeting of the Radiological Society of North America (RSNA 2016), Bracco Diagnostics Inc. showcased...
GlobalData, contrast media injectors market,
News | Contrast Media Injectors | May 03, 2016
The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 billion by...
CTA, CT, contrast media injector, contrast injector, EmpowerCTA

Bracco's new EmpowerCTA+, designed for cardiac CT angiography exams.

Feature | Contrast Media Injectors | April 29, 2016 | Jeff Zagoudis
The biggest trend in contrast media injector technology today is one seen throughout all of healthcare — doing more...